LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Dura Pharmaceuticals Inc.
Headquarters:
United States of America
Website:
N/A
Year Founded:
1981
Status:
Acquired
BioCentury
|
Jan 17, 2005
Regulation
Timing losses in stock fraud
Read More
BioCentury
|
Jul 5, 2004
Politics, Policy & Law
Buy and sue
Read More
BioCentury
|
Apr 30, 2001
Company News
Xcel board of directors update
Read More
BioCentury
|
Apr 30, 2001
Company News
Xcel management update
Read More
BioCentury
|
Apr 9, 2001
Company News
Alkermes, Eli Lilly deal
Read More
BioCentury
|
Mar 19, 2001
Company News
Epicyte management update
Read More
BioCentury
|
Jan 22, 2001
Company News
Elan management update
Read More
BioCentury
|
Nov 13, 2000
Company News
Elan, Dura deal
Read More
BioCentury
|
Oct 23, 2000
Clinical News
Dry powder inhalation technology regulatory update
Read More
BioCentury
|
Oct 9, 2000
Company News
Dura, Glaxo Wellcome deal
Read More
Items per page:
10
1 - 10 of 111